Birchview Capital, LP Protagonist Therapeutics, Inc Transaction History

Birchview Capital, LP

  • $124 Million
  • Q3 2025

A detailed history of Birchview Capital, LP transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Birchview Capital, LP holds 48,000 shares of PTGX stock, worth $4.06 Million. This represents 2.57% of its overall portfolio holdings.

Number of Shares
48,000
Previous 48,000 -0.0%
Holding current value
$4.06 Million
Previous $2.65 Million 20.21%
% of portfolio
2.57%
Previous 2.79%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$40.89 - $56.37 $81 - $112
-2 Reduced -0.0%
48,000 $2.65 Million
Q1 2025

May 15, 2025
BUY
$35.09 - $59.76 $70 - $119
2 Added 0.0%
48,002 $2.32 Million
Q1 2024

May 14, 2024
BUY
$21.79 - $32.15 $217,900 - $321,500
10,000 Added 26.32%
48,000 $1.39 Million
Q4 2023

Jun 30, 2025
BUY
$14.05 - $23.44 $140,500 - $234,400
10,000 Added 26.32%
48,000 $1.1 Million
Q3 2023

Jun 30, 2025
SELL
$16.68 - $23.66 $166,833 - $236,647
-10,002 Reduced 20.84%
38,000 $633,000
Q3 2021

Nov 12, 2021
BUY
$12.95 - $49.69 $362,600 - $1.39 Million
28,000 Added 280.0%
38,000 $673,000
Q1 2021

May 14, 2021
BUY
$19.02 - $31.15 $190,200 - $311,500
10,000 New
10,000 $259,000

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $4.15B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Birchview Capital, LP Portfolio

Follow Birchview Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email